Finally, combining 015s with the CD24-targeted ADC cG7-MMAE yielded superior antitumour efficacy in the MC38-hCD24 colorectal model, providing initial proof that dual PD-1/TGF-β blockade can cooperate with ADC therapy in cancer treatment. Here, CD24 is linked to cancer.